FMP
TheraVet SA
ALVET.PA
EURONEXT
Inactive Equity
TheraVet SA, a veterinary biotechnology company, provides osteoarticular treatments for animals in Belgium, France, Switzerland, the United Kingdom, and the United States. The company primarily provides products for osteoarthritis, ligament and tendon injuries, and bone surgery in cats, dogs, and horses. It offers BIOCERA-VET for osseointegration and bone remodelling; and VISCO-VET, an injectable visco-regenerative gel based on hyaluronic acid with anti-inflammatory properties that promotes the effect of active components, as well as acts as a cell colonization supporting tissue regeneration. The company was incorporated in 2017 and is headquartered in Jumet, Belgium.
0.082 EUR
0 (0%)
Valuation Date:
Jan 27, 2025 11:35 AM
Share Price on Valuation Date
$0.08
Stock Beta
-0.493
Shares Outstanding
3569175